Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1841 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
filingDate |
1993-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
1996-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H08500823-A |
titleOfInvention |
Bystander suppression of retrovirus-related neurological disorders |
abstract |
(57) [Summary]nThe present invention relates to a method of treating a mammal suffering from a retrovirus-related neurological disease by administering an effective amount of a bystander antigen. The bystander antigen is selected such that suppressor T cells release transforming growth factor β (TGF-β). Preferably, the target of T cells is attacked by a cytotoxic attack during the neurological disease. The selected body part (ie, nerve tissue) in the body of the mammal receiving the disease is selected. The released TGF-β suppresses cells involved in cytotoxic attack and reduces neurological disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001507360-A |
priorityDate |
1992-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |